Literature DB >> 9751236

Improvements in blood pressure, glucose metabolism, and lipoprotein lipids after aerobic exercise plus weight loss in obese, hypertensive middle-aged men.

D R Dengel1, J M Hagberg, R E Pratley, E M Rogus, A P Goldberg.   

Abstract

The clustering of metabolic abnormalities often associated with hypertension, including insulin resistance, glucose intolerance, and dyslipidemia, in middle-aged men may be the result of a decrease in cardiovascular fitness (VO2max) and the accumulation of body fat with aging. This study examines the effects of a 6-month program of aerobic exercise training plus weight loss (AEX+WL) on VO2max, body composition, blood pressure (BP), glucose and insulin responses during an oral glucose tolerance test (OGTT), glucose infusion rates (GIR) during 3-dose hyperinsulinemic-euglycemic clamps at insulin infusion rates of 120, 600, and 3,000 pmol x m(-2) x min(-1), and plasma lipoprotein levels. Compared with eight non-obese, normotensive, sedentary men (age, 62+/-2 years; 19%+/-2% fat; BP, 117+/-4/72+/-2 mm Hg), the nine obese, hypersensitive, sedentary men studied (age, 56+/-1 year; 32%+/-1% body fat; BP, 147+/-3/93+/-2 mm Hg) initially had a larger waist girth and waist-to-hip ratio (WHR) and were more hyperinsulinemic and insulin resistant with lower GIR at the two lower insulin infusion rates of the clamp and had a 2.9-fold higher EC50, the insulin concentration producing a half-maximal increase in GIR. They had higher triglyceride (TG) and lower high-density lipoprotein cholesterol (HDL-C) levels. The AEX+WL intervention reduced body weight by 9%, percent body fat by 21%, waist girth by 9%, and WHR by 3%, and increased VO2max by 16% (P < .01 for all). This was associated with decreases of 14+/-3 mm Hg in systolic and 10+/-2 mm Hg in diastolic BP, significant changes in GIR at the low (+42%) and intermediate (+39%) insulin infusion rates and EC50 (-39%) and in glucose (-21%) and insulin (-51%) responses during OGTT (P < .02 for all). AEX+WL also lowered total cholesterol by 14% and TG by 34%, and raised HDL2-C levels twofold (P < .01 for all). Thus, a 6-month AEX+WL intervention substantially lowers BP and improves glucose and lipid metabolism in obese, sedentary, hypertensive men. This suggests that hypertension and the metabolic risk factors for cardiovascular disease associated with it can be ameliorated by AEX+WL in obese, sedentary, middle-aged men.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9751236     DOI: 10.1016/s0026-0495(98)90281-5

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  24 in total

Review 1.  Studies examining risk reduction in subjects with multiple metabolic and cardiovascular risk factors.

Authors:  M L Tuck; D B Corry
Journal:  Curr Hypertens Rep       Date:  2000-04       Impact factor: 5.369

2.  Insulin resistance in pulmonary arterial hypertension.

Authors:  R T Zamanian; G Hansmann; S Snook; D Lilienfeld; K M Rappaport; G M Reaven; M Rabinovitch; R L Doyle
Journal:  Eur Respir J       Date:  2008-12-01       Impact factor: 16.671

Review 3.  The role of exercise training in the treatment of hypertension: an update.

Authors:  J M Hagberg; J J Park; M D Brown
Journal:  Sports Med       Date:  2000-09       Impact factor: 11.136

Review 4.  Muscle mechanoreflex overactivity in hypertension: a role for centrally-derived nitric oxide.

Authors:  Scott A Smith; Anna K Leal; Megan N Murphy; Ryan M Downey; Masaki Mizuno
Journal:  Auton Neurosci       Date:  2015-01-02       Impact factor: 3.145

5.  Can physiology zap therapeutic sweet spots in hypertension?

Authors:  Michael J Joyner
Journal:  Hypertension       Date:  2012-10-08       Impact factor: 10.190

Review 6.  A model of long-term metabolic progression of type 2 diabetes mellitus for evaluating treatment strategies.

Authors:  Adrian Bagust; Marc Evans; Sophie Beale; Philip D Home; Andrew S Perry; Murray Stewart
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

7.  Exercise training enhanced the expression of myocardial proteins related to cell protection in spontaneously hypertensive rats.

Authors:  Claude Lajoie; Angelino Calderone; Louise Béliveau
Journal:  Pflugers Arch       Date:  2004-10       Impact factor: 3.657

8.  Fibroblast growth factor 21 is required for beneficial effects of exercise during chronic high-fat feeding.

Authors:  Christine Loyd; I Jack Magrisso; Michael Haas; Sowmya Balusu; Radha Krishna; Nobuyuki Itoh; Darleen A Sandoval; Diego Perez-Tilve; Silvana Obici; Kirk M Habegger
Journal:  J Appl Physiol (1985)       Date:  2016-07-21

Review 9.  Cardiometabolic syndrome: pathophysiology and treatment.

Authors:  Jonathan P Castro; Fadi A El-Atat; Samy I McFarlane; Ashish Aneja; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2003-10       Impact factor: 5.369

Review 10.  Effects of antioxidant supplementation on the aging process.

Authors:  Domenico Fusco; Giuseppe Colloca; Maria Rita Lo Monaco; Matteo Cesari
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.